title: Understanding the immunoangiostatic CXC chemokine network.
abstract: Chemokines, originally discovered as mediators of directional migration of immune cells to sites of inflammation and injury, have a function beyond their role in leukocyte chemotaxis. Indeed, they participate in organ development, angiogenesis, tumourigenesis and, more importantly, in the immune response. The chemokine family characterized by four highly conserved cysteine amino acid residues, with two cysteine residues (C) and a non-cysteine amino acid (X) between them (CXC), is known for its ability to promote trafficking of various leukocytes and to regulate angiogenesis and vascular remodelling. Intriguingly, the presence or absence of a structural-functional domain constituted by glutamic acid-leucine-arginine motif that precedes the first cysteine amino acid residue accounts for their unique property to induce or inhibit angiogenesis (angiogenic or angiostatic activity). The ability of CXC chemokine receptor 3 to promote Th1-dependent immunity and, at the same time, inhibit angiogenesis (immunoangiostasis) is of critical importance for inducing tumour regression. Agents that are able to inhibit angiogenic activities or promote angiostatic activities of CXC chemokines are future targets for research on cancer treatment. Here, we review insights on CXC chemokines in the context of immunoangiostasis and vascular damage.
authors.affiliation: Department of Biochemistry and Biophysics, 1st School of Medicine, II University of Naples, Naples 80138, Italy.
authors.forename: Maria Luisa
authors.initials: ML
authors.lastname: Balestrieri
authors.forename: Antonio
authors.initials: A
authors.lastname: Balestrieri
authors.forename: Francesco Paolo
authors.initials: FP
authors.lastname: Mancini
authors.forename: Claudio
authors.initials: C
authors.lastname: Napoli
mesh_terms: D042501:Angiogenic Proteins / Q000378:metabolism; D043165:Angiostatic Proteins / Q000378:metabolism; D000818:Animals; D019743:Chemokines, CXC / Q000378:metabolism*; D042783:Endothelial Cells / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D009389:Neovascularization, Pathologic / Q000276:immunology / Q000503:physiopathology; D018919:Neovascularization, Physiologic / Q000276:immunology*; D054387:Receptors, CXCR / Q000378:metabolism*; D054367:Receptors, CXCR3 / Q000378:metabolism; D015398:Signal Transduction / Q000276:immunology*
chemical_list: D042501:Angiogenic Proteins; D043165:Angiostatic Proteins; D019743:Chemokines, CXC; D054387:Receptors, CXCR; D054367:Receptors, CXCR3